Form 4: UiPath CEO Sells 45,000 Shares Under 10b5-1 Plan
Insider Trading Disclosure
UiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $19.21 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH), reported the sale of 45,000 shares of Class A Common Stock.
- The transaction occurred on December 8, 2025, at an average price of $19.2135 per share, with prices ranging from $19.1500 to $19.4100.
- The sale was executed in compliance with a qualified selling plan adopted by Mr. Dines pursuant to Rule 10b5-1.
- Following this transaction, Mr. Dines directly beneficially owns 29,198,585 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While it's an insider sale, the execution under a Rule 10b5-1 plan mitigates potential negative interpretations, indicating a pre-planned financial management activity rather than a reaction to adverse company developments.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on new, non-public information, which enhances transparency and reduces concerns about opportunistic insider selling.
Negatives
- A reduction in direct ownership by a key executive, even if pre-planned, can sometimes be perceived by the market as a slight negative signal, as it decreases the insider's direct stake in the company.
Risks
- No specific risks are detailed in this Form 4 filing beyond the general market perception of insider selling.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This transaction is a routine insider trading disclosure and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual executive's financial planning rather than a strategic company move.
Stakeholder Impact
- Shareholders: The sale by a key executive could lead to minor short-term market speculation, but the 10b5-1 plan context typically limits significant negative impact. The executive still retains a substantial stake.
- Employees, Customers, Suppliers, Creditors: No direct impact is expected from this routine insider transaction.
Key Dates
| Date | Description |
|---|---|
| 12/08/2025 | Date of transaction for the sale of Class A Common Stock by Daniel Dines. |
Keywords
UiPath, PATH, Daniel Dines, Insider Sale, Form 4, 10b5-1 Plan, Class A Common Stock, CEO, Chairman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.